Top Institutions in Dermatology
Institutions were ranked based on their known leadership in psoriasis research, clinical trials involving biologic and oral systemic therapies, and contributions to understanding inflammatory pathways such as IL-23 in dermatologic diseases.
-
#1
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
The University of Pennsylvania is a leader in psoriasis research, with extensive clinical trials on biologics and novel systemic agents targeting IL-23 and related pathways. Their dermatology department is internationally recognized for translational research and patient care in inflammatory skin diseases.
Key Differentiators
- Dermatology
- Immunology
- Clinical Research
-
#2
University of California, San Francisco (UCSF) School of Medicine
San Francisco, CA
UCSF has a strong clinical research program in psoriasis and inflammatory skin diseases, with active involvement in systemic therapy trials and expertise in immunomodulatory treatments including IL-23 pathway inhibitors.
Key Differentiators
- Dermatology
- Clinical Trials
- Immunodermatology
-
#3
Mayo Clinic
Rochester, MN
Mayo Clinic is renowned for its multidisciplinary approach to psoriasis, combining clinical trials with comprehensive patient management, including novel oral and biologic therapies targeting inflammatory pathways such as IL-23.
Key Differentiators
- Dermatology
- Clinical Research
- Autoimmune Diseases
-
#4
Stanford University School of Medicine
Stanford, CA
Stanford has a robust research program in inflammatory skin diseases, focusing on molecular mechanisms and clinical trials of targeted therapies including IL-23 receptor antagonists for psoriasis.
Key Differentiators
- Dermatology
- Immunology
- Translational Research
-
#5
Cleveland Clinic
Cleveland, OH
Cleveland Clinic is recognized for its clinical expertise in psoriasis management and involvement in clinical trials evaluating systemic therapies including IL-23 inhibitors, with a focus on improving patient quality of life.
Key Differentiators
- Dermatology
- Clinical Trials
- Autoimmune Skin Disorders
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
